Last reviewed · How we verify

NCT04963816: QLB

Pediatric Postoperative Analgesia With Quadratus Lumborum Block(QLB) And Dexamethasone As An Adjuvant To Bupivacaine.

Completed NA Last updated 3 February 2022
What this trial tests

NA trial testing ultrasound guided quadratus lumborum block in Post Operative Pain in 3 participants. Completed in 10 January 2022.

Timeline
16 June 2021
Primary endpoint
30 October 2021
10 January 2022

Quick facts

Lead sponsorTanta University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment3
Start date16 June 2021
Primary completion30 October 2021
Estimated completion10 January 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 6 to 12, any sex, with Post Operative Pain or Quadratus Lumborum Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studying the post-operative analgesic effect of dexamethasone as an adjuvant to bupivacaine giving intravenously and locally with ultrasound guided quadratus lumborum block(QLB) in pediatrics undergoing abdominal surgeries

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ultrasound guided quadratus lumborum block

Trials testing the same drug.

Other recruiting trials for Post Operative Pain

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04963816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing